1. Home
  2. CABO vs CUVL Comparison

CABO vs CUVL Comparison

Compare CABO & CUVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cable One Inc.

CABO

Cable One Inc.

BUY

Current Price

$5.57

Market Cap

425.5M

ML Signal

BUY

Logo Clinuvel Pharmaceuticals Limited American Depositary Shares

CUVL

Clinuvel Pharmaceuticals Limited American Depositary Shares

N/A

Current Price

$5.00

Market Cap

374.2M

Sector

Miscellaneous

ML Signal

N/A

Company Overview

Basic Information
Metric
CABO
CUVL
Founded
1980
1999
Country
United States
Australia
Employees
N/A
16
Industry
Cable & Other Pay Television Services
Miscellaneous
Sector
Telecommunications
Miscellaneous
Exchange
Nasdaq
Nasdaq
Market Cap
425.5M
374.2M
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
CABO
CUVL
Price
$5.57
$5.00
Analyst Decision
Hold
Analyst Count
6
0
Target Price
★ $44.25
N/A
AVG Volume (30 Days)
★ 803.4K
4.9K
Earning Date
11-05-2026
08-27-2026
Dividend Yield
N/A
★ 0.56%
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $1,501,423,000.00
N/A
Revenue This Year
N/A
$0.89
Revenue Next Year
$4.86
$6.69
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$5.37
$4.91
52 Week High
$167.36
$8.20

Technical Indicators

Market Signals
Indicator
CABO
CUVL
Relative Strength Index (RSI) 26.87 30.44
Support Level N/A $4.91
Resistance Level $16.31 $6.04
Average True Range (ATR) 2.13 0.15
MACD -0.11 -0.02
Stochastic Oscillator 1.92 10.09

Price Performance

Historical Comparison
CABO
CUVL

About CABO Cable One Inc.

Cable One Inc is a telecommunications company that generates revenue from providing broadband, voice, and video services to both residential and business customers. The company derives majority of its revenue from data and video services, which are subscription-based and billed monthly. The company also offers Sparklight TV, an Internet Protocol Television (IPTV) service that enables customers using the Sparklight TV app to stream video channels from the cloud. Additionally, the company earns advertising revenue by selling airtime on its video channels, and it provides voice services over Internet protocols.

About CUVL Clinuvel Pharmaceuticals Limited American Depositary Shares

Clinuvel distributes a single product, Scenesse, the only approved treatment for phototoxic reactions specifically associated with a rare genetic disease called erythropoietic protoporphyria. EPP causes extreme pain or burns from brief exposure to light, affecting a patient's quality of life. Scenesse is a patented dissolvable implant, comparable in size with a rice grain, injected underneath the skin roughly every three months for ongoing protection. The implant controls the release of a synthetic drug which promotes the production of more melanin, thereby reducing pain and increasing tolerance for light exposure. The majority of Clinuvel's earnings stem from Europe and the US.

Share on Social Networks: